论文信息 - Opioid peptidomimetics: leads for the design of bioavailable mixed efficacy μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands. - 字舞流文

Opioid peptidomimetics: leads for the design of bioavailable mixed efficacy μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands.

E. Jutkiewicz | H. Mosberg | J. Traynor | Aaron M. Bender | M. Clark | K. Sobczyk-Kojiro | L. Yeomans | Jessica P. Anand | Aubrie A. Harland | K. Sobczyk‐Kojiro